The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 12, 2025
Filed:
Jan. 07, 2022
Applicant:
Janssen Biotech, Inc., Horsham, PA (US);
Inventors:
Sven-Erik Strand, Lund, SE;
Amanda Thuy Tran, Stockholm, SE;
Sven-Niklas Anders Axelsson, Bjarred, SE;
Assignee:
Janssen Biotech, Inc., Horsham, PA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 47/68 (2017.01); A61K 49/16 (2006.01); A61K 49/22 (2006.01); A61K 51/10 (2006.01); C07K 16/18 (2006.01); C07K 16/30 (2006.01); C07K 16/40 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
A61K 51/1072 (2013.01); A61K 47/6803 (2017.08); A61K 49/16 (2013.01); A61K 49/221 (2013.01); A61K 51/1018 (2013.01); A61K 51/1075 (2013.01); A61K 51/1093 (2013.01); A61K 51/1096 (2013.01); C07K 16/18 (2013.01); C07K 16/3069 (2013.01); C07K 16/40 (2013.01); G01N 33/57434 (2013.01); C07K 2317/565 (2013.01); G01N 2333/96455 (2013.01);
Abstract
The present application provides an agent comprising or consisting of a binding moiety with specificity for a kallikrein protein (for example, PSA or hK2) for use in the treatment of prostate cancer, and a method for the treatment of prostate cancer in a patient, the method comprising the step of administering a therapeutically effective amount of an agent comprising or consisting of a binding moiety with specificity for a kallikrein protein to the patient.